Publications
Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review
This review investigated research on prison prescribing programmes to establish whether the spread of HIV may be as reduced there as it is in the community. Drug and Alcohol Findings, UK
This review investigated research on prison prescribing programmes to establish whether the spread of HIV may be as reduced there as it is in the community. Drug and Alcohol Findings, UK
Neptune: Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances
Project NEPTUNE (Novel Psycho Active Treatment: UK Network), have released guidance to improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances.
Project NEPTUNE (Novel Psycho Active Treatment: UK Network), have released guidance to improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances.
Adding a dedicated public health approach to the international drug control regime
This letter addresses illicit substances treated under the international drug control framework. Authors have designed a possible outline to be negotiated in 2019, based on the one adopted in 2009. A new public health approach to the international strategy on drugs has been added.
This letter addresses illicit substances treated under the international drug control framework. Authors have designed a possible outline to be negotiated in 2019, based on the one adopted in 2009. A new public health approach to the international strategy on drugs has been added.
Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis
This review provides updated and expanded information regarding rates of problematic opioid use in chronic pain.
This review provides updated and expanded information regarding rates of problematic opioid use in chronic pain.
Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus
'Mass treatment programs to cure the hepatitis C virus in developing countries are only feasible if the costs of treatment and laboratory diagnostics are low.' This article offers the minimum costs of direct-acting antiviral treatment and associated diagnostic monitoring.
'Mass treatment programs to cure the hepatitis C virus in developing countries are only feasible if the costs of treatment and laboratory diagnostics are low.' This article offers the minimum costs of direct-acting antiviral treatment and associated diagnostic monitoring.
The cost-effectiveness of harm reduction
A commentary on the effectiveness of harm reduction services and their cost-effectiveness with respect to HIV-related outcomes.
A commentary on the effectiveness of harm reduction services and their cost-effectiveness with respect to HIV-related outcomes.
Integrated care increases treatment and improves outcomes of patients with chronic hepatitis C virus infection and psychiatric illness or substance abuse
Investigating whether an integrated care protocol could increase the proportion of patients with chronic hepatitis C virual infection who receive antiviral treatment and achieve a sustained virologic response.
Investigating whether an integrated care protocol could increase the proportion of patients with chronic hepatitis C virual infection who receive antiviral treatment and achieve a sustained virologic response.
Take-home naloxone to prevent fatalities from opiate-overdose: Protocol for Scotland’s public health policy evaluation, and a new measure to assess impact.
Scotland was the first country to adopt take-home naloxone as a funded public health policy. This paper summarises the background and monitoring required when assessing the impact on high-risk opiate-fatalities.
Scotland was the first country to adopt take-home naloxone as a funded public health policy. This paper summarises the background and monitoring required when assessing the impact on high-risk opiate-fatalities.
Hepatitis C treatment factsheets
Infohep.org have published a series of hepatitis C treatment factsheets, including the newly published factsheet on Harvoni, which was approved in Europe in November 2014.
Infohep.org have published a series of hepatitis C treatment factsheets, including the newly published factsheet on Harvoni, which was approved in Europe in November 2014.
A more personalised approach to hepatitis C treatment may improve adherence and completion rates
Adherence in treatment for hepatitis C is improved by clinicians who give clinical feedback and information that is personalised to patients' individual needs and lifestyle
Adherence in treatment for hepatitis C is improved by clinicians who give clinical feedback and information that is personalised to patients' individual needs and lifestyle
